Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
MacroGenics
About
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
- 501 - 1000
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $9.80M
- Industries
- Biotechnology,Health Care,Manufacturing
- Founded date
- Jan 1, 2000
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases.The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology.The company was founded in 2000 and is headquartered in Rockville, Maryland.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2010 | Grant | $9.80M | 1 |
National Institutes of Health
|
— | Detail |
| Oct 23, 2008 | Series D | $25M | 3 | — | — | Detail |
| Jul 29, 2008 | Series D | $12.50M | 1 | — | — | Detail |
| May 17, 2006 | Series C | $45M | 1 | — | — | Detail |
| Oct 15, 2004 | Series B | $30.50M | 3 |
TPG
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
TPG
|
— | Series D |
CIDC Consultants
|
— | Series D |
|
|
— | Series D |
|
|
— | Series B |
|
|
— | Series B |
